On November 30th, 2021
Umbrella Study of Sasanlimab Combined with Targeted Therapies for NSCLC
Who We ARE:
Advocacy - Your Voice in State & National Advocacy
Relationships - Your Partner in Cancer Care
Education: Administration, Business, Clinical
JOIN OR RENEW NOW
Advocacy - Your Voice in State & National Advocacy
Relationships - Your Partner in Cancer Care
Education: Administration, Business, Clinical
Contact
- P.O. Box 161
- Upland, CA 91785
- P: 909-985-9061
- F: 909-804-5006
- moasc@moasc.org
No comments have been posted yet.